Clinical practice guidelines for the care of girls and women with Turner syndrome: proceedings from the 2016 Cincinnati International Turner Syndrome Meeting
Клинические рекомендации по медицинской помощи девочкам и женщинам с синдромом Тёрнера: материалы Международной конференции по синдрому Тёрнера, состоявшейся в Цинциннати в 2016 году
2017-07-13
SCID: 54.1/2dg5hq8w
Discuss with AI
Turner syndromecardiovascular diseaseclinical practice guidelineshormone replacement therapymultidisciplinary care
Figures from the paper
Abstract (AI)
Turner syndrome affects 25-50 per 100,000 females and can involve multiple organs through all stages of life, necessitating multidisciplinary approach to care. Previous guidelines have highlighted this, but numerous important advances have been noted recently. These advances cover all specialty fields involved in the care of girls and women with TS. This paper is based on an international effort that started with exploratory meetings in 2014 in both Europe and the USA, and culminated with a Consensus Meeting held in Cincinnati, Ohio, USA in July 2016. Prior to this meeting, five groups each addressed important areas in TS care: 1) diagnostic and genetic issues, 2) growth and development during childhood and adolescence, 3) congenital and acquired cardiovascular disease, 4) transition and adult care, and 5) other comorbidities and neurocognitive issues. These groups produced proposals for the present guidelines. Additionally, four pertinent questions were submitted for formal GRADE (Grading of Recommendations, Assessment, Development and Evaluation) evaluation with a separate systematic review of the literature. These four questions related to the efficacy and most optimal treatment of short stature, infertility, hypertension, and hormonal replacement therapy. The guidelines project was initiated by the European Society for Endocrinology and the Pediatric Endocrine Society, in collaboration with The European Society for Pediatric Endocrinology, The Endocrine Society, European Society of Human Reproduction and Embryology, The American Heart Association, The Society for Endocrinology, and the European Society of Cardiology. The guideline has been formally endorsed by the European Society for Endocrinology, the Pediatric Endocrine Society, the European Society for Pediatric Endocrinology, the European Society of Human Reproduction and Embryology and the Endocrine Society. Advocacy groups appointed representatives who participated in pre-meeting discussions and in the consensus meeting.
Key Findings
1
An international consensus process produced updated Turner syndrome recommendations spanning diagnosis and genetics, growth, cardiovascular disease, transition, adult care, comorbidities, and neurocognitive issues.
2
Four priority clinical questions—short stature treatment, infertility, hypertension, and hormone replacement therapy—underwent formal GRADE evaluation supported by systematic literature reviews.
3
The guideline initiative involved multiple international endocrine, cardiology, reproductive medicine, and advocacy organizations and received formal endorsement from five major professional societies.
4
The guidelines establish a multidisciplinary, lifespan approach to caring for girls and women with Turner syndrome, reflecting its multisystem involvement.
Research Object
girls and women with Turner syndrome
Research Subject
multidisciplinary clinical care and evidence-based management across the lifespan, including diagnosis, growth, cardiovascular disease, fertility, hypertension, hormone replacement, comorbidities, and neurocognitive issues
Publication Details
Publication Date
2017-07-13
Journal
Publisher
ISSN
Cited by
1099
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest